Familial cancer syndromes and genetic counseling.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cancer treatment and research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4615-5767-8_3PMID 9494758
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

  1998cited by this paper
• Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy.

  1997cited by this paper
• The use and interpretation of commercial APC gene testing for familial adenomatous polyposis.

  1997cited by this paper
• Hereditary retinoblastoma, lipoma, and second primary cancers.

  1997cited by this paper
• Resource document for curriculum development in cancer genetics education. American Society of Clinical Oncology.

  1997cited by this paper
• Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.

  1996cited by this paper
• Report of a critical recombination further narrowing the TSC1 region.

  1996cited by this paper
• Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome

  1996cited by this paper
• Germline WT1 mutations in Wilms' tumor patients: preliminary results.

  1996cited by this paper
• Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome

  1996cited by this paper
• Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

  1996cited by this paper
• Germline mutations in the Von Hippel‐Lindau disease (VHL) gene in families from North America, Europe, and Japan

  1996cited by this paper
• Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. Commentaries

  1996cited by this paper
• Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12–q21

  1996cited by this paper
• A genetic register for von Hippel-Lindau disease.

  1996cited by this paper
• Regions in β-Chemokine Receptors CCR5 and CCR2b That Determine HIV-1 Cofactor Specificity

  1996cited by this paper
• Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.

  1996cited by this paper
• Patterns of childhood cancer among siblings.

  1996cited by this paper
• Molecular genetics of neurofibromatosis type 1 (NF1).

  1996cited by this paper
• Attitudes of 47 mothers of pediatric oncology patients toward genetic testing for cancer predisposition.

  1996cited by this paper
• Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.

  1996cited by this paper
• Clinical overlap of Beckwith‐Wiedemann, Perlman and Simpson‐Golabi‐Behmel syndromes: a diagnostic pitfall

  1995cited by this paper
• A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

  1995cited by this paper
• Testing for cancer genes: Decisions, decisions

  1995cited by this paper
• Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.

  1995cited by this paper
• Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma.

  1995cited by this paper
• The molecular basis of Turcot's syndrome.

  1995cited by this paper
• Tuberous sclerosis associated with histologically confirmed ocular and cerebral tumors.

  1995cited by this paper
• Distribution of 13 truncating mutations in the neurofibromatosis 1 gene.

  1995cited by this paper
• Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITY (*)

  1995cited by this paper
• Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors.

  1995cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1995cited by this paper
• Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6‐year follow‐up

  1995cited by this paper
• Genetic testing for children and adolescents.

  1995cited by this paper
• Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.

  1995cited by this paper
• The Bloom's syndrome gene product is homologous to RecQ helicases.

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Two loci for Tuberous Sclerosis: one on 9q34 and one on 16p13

  1994cited by this paper
• A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

  1994cited by this paper
• Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family.

  1994cited by this paper
• Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer

  1994cited by this paper
• Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

  1994cited by this paper
• Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma.

  1994cited by this paper
• A de novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors.

  1994cited by this paper
• Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.

  1994cited by this paper
• High frequency of germline p53 mutations in childhood adrenocortical cancer.

  1994cited by this paper
• Germ‐line and somatic mutations of the APC gene in patients with turcot syndrome and analysis of APC mutations in brain tumors

  1994cited by this paper
• Germline p16 mutations in familial melanoma

  1994cited by this paper
• Mutational analysis of patients with neurofibromatosis 2.

  1994cited by this paper
• Genetic testing for children and adolescents. Who decides?

  1994cited by this paper
• Analysis of paediatric tumour types associated with hemihyperplasia in childhood

  1994cited by this paper
• Mapping of Simpson-Golabi-Behmel syndrome to Xq25-q27.

  1994cited by this paper
• Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.

  1994cited by this paper
• Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

  1994cited by this paper
• Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations

  1994cited by this paper
• Germline mutations in the neurofibromatosis type 2 tumour suppressor gene.

  1994cited by this paper
• Mutation of a mutL homolog in hereditary colon cancer.

  1994cited by this paper
• Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test.

  1994cited by this paper
• Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.

  1994cited by this paper
• A Mutation in the RET Protooncogene Associated with Multiple Endocrine Neoplasia Type 2B and Sporadic Medullary Thyroid Carcinoma

  1994cited by this paper
• Gene for Simpson-Golabi-Behmel syndrome is linked to HPRT in Xq26 in two European families.

  1994cited by this paper
• Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation.

  1994cited by this paper
• Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.

  1994cited by this paper
• Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms tumor: a report from the National Wilms Tumor Study.

  1993cited by this paper
• Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1.

  1993cited by this paper
• Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer.

  1993cited by this paper
• The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.

  1993cited by this paper
• Germ-line mutations in the first 14 exons of the adenomatous polyposis coli (APC) gene.

  1993cited by this paper
• Identification of the von Hippel-Lindau disease tumor suppressor gene.

  1993cited by this paper
• Complete genomic sequence of the human retinoblastoma susceptibility gene.

  1993cited by this paper
• Alleles of the APC gene: an attenuated form of familial polyposis.

  1993cited by this paper
• Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma

  1993cited by this paper
• Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.

  1993cited by this paper
• Precursor lesions of Wilms tumor: clinical and biological implications.

  1993cited by this paper
• A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm.

  1993cited by this paper
• Low frequency of mutations in the WT1 coding region in Wilms' tumor

  1993cited by this paper
• Wilms' tumor in the Li-Fraumeni cancer family syndrome.

  1993cited by this paper
• Neurofibromatosis type 1 and childhood cancer

  1993cited by this paper
• Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis.

  1993cited by this paper
• Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A

  1993cited by this paper
• Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients.

  1993cited by this paper
• A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

  1993cited by this paper
• Mortality from second tumors among long-term survivors of retinoblastoma.

  1993cited by this paper
• Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings.

  1993cited by this paper
• Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

  1993cited by this paper
• Genetic mapping of a locus predisposing to human colorectal cancer.

  1993cited by this paper
• Molecular diagnosis of familial adenomatous polyposis.

  1993cited by this paper
• Identification of APC gene mutations in Italian adenomatous polyposis coli patients by PCR-SSCP analysis.

  1993cited by this paper
• Follow-up of retinoblastoma patients having prenatal and perinatal predictions for mutant gene carrier status using intragenic polymorphic probes from the RB1 gene.

  1992cited by this paper
• Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis.

  1992cited by this paper
• Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals.

  1992cited by this paper
• Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.

  1992cited by this paper
• Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas.

  1992cited by this paper
• Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.

  1992cited by this paper
• Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.

  1992cited by this paper
• Germ-line splicing mutation of the p53 gene in a cancer-prone family.

  1992cited by this paper
• Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype.

  1992cited by this paper
• Absence of hereditary p53 mutations in 10 familial leukemia pedigrees.

  1992cited by this paper
• Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients.

  1992cited by this paper
• A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling.

  1992cited by this paper

• Central Nervous System and Peripheral Nerves

  2018cites this paper
• Population-based study of familial medullary thyroid cancer

  2004cites this paper
• Familial risk of cancer by site and histopathology

  2003cites this paper
• Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family‐cancer database

  2002cites this paper
• Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers

  2001cites this paper
• Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families

  2001cites this paper
• Functional genomics: clinical effect and the evolving role of the surgeon.

  1999cites this paper